A detailed history of Quantbot Technologies LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Quantbot Technologies LP holds 3,032 shares of LEGN stock, worth $129,102. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,032
Holding current value
$129,102
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$43.55 - $59.88 $132,043 - $181,556
3,032 New
3,032 $147,000
Q2 2022

Aug 09, 2022

SELL
$33.54 - $55.0 $365,586 - $599,500
-10,900 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $335,016 - $520,344
10,800 Added 10800.0%
10,900 $396,000
Q4 2021

Feb 11, 2022

BUY
$41.14 - $56.98 $4,114 - $5,698
100 New
100 $4,000
Q3 2021

Nov 09, 2021

SELL
$35.31 - $50.56 $91,806 - $131,456
-2,600 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$25.8 - $41.09 $67,080 - $106,834
2,600 New
2,600 $106,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.13B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.